ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Top Psychiatry Prescribers in Massachusetts

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
EVGENIY FILIN M.D.

Psychiatry

2,420

$250K

155
47 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 20%

$104
Average prescription price

Avg: $110

ALEXANDER VUCKOVIC M.D.

Psychiatry

2,416

$247K

100
53 are 65+

12%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 20%

$102
Average prescription price

Avg: $110

PHILIPPE SIOUFI M.D.

Psychiatry

2,416

$204K

246
24 are 65+

9%
patients receiving schedule two controlled substances

Avg: 5%

7%
patients receiving schedule three controlled substances

Avg: 2%

11%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 20%

$84
Average prescription price

Avg: $110

RICHARD KAISER M.D.

Psychiatry

2,410

$266K

131
79 are 65+

14%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 20%

$110
Average prescription price

Avg: $110

CATHERINE DURIE M.D.

Psychiatry

2,406

$235K

127
19 are 65+

18%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 20%

$98
Average prescription price

Avg: $110

HOP TRINH M.D.

Psychiatry

2,377

$155K

128
81 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

14%
prescriptions for brand name drugs

Avg: 20%

$65
Average prescription price

Avg: $110

SLAVENKA MILUTIN MD

Psychiatry

2,367

$274K

154
63 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 20%

$116
Average prescription price

Avg: $110

WILLIAM BOUTELLE M.D.

Psychiatry

2,351

$290K

120
15 are 65+

22%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 20%

$123
Average prescription price

Avg: $110

ERICH GOETZEL M.D.

Psychiatry

2,322

$319K

56
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 20%

$137
Average prescription price

Avg: $110

GEORGE SIGEL M.D.

Psychiatry

2,315

$249K

190
58 are 65+

11%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 20%

$108
Average prescription price

Avg: $110

L. RUSSELL PET M.D.

Psychiatry

2,293

$299K

132
54 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 20%

$130
Average prescription price

Avg: $110

DAVID HENDERSON MD

Psychiatry

2,285

$334K

116
17 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 20%

$146
Average prescription price

Avg: $110

OLIVER FREUDENREICH MD

Psychiatry

2,266

$272K

175
16 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

13%
prescriptions for brand name drugs

Avg: 20%

$120
Average prescription price

Avg: $110

MICHAEL LAVARNWAY MD

Psychiatry

2,247

$151K

176
18 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

12%
prescriptions for brand name drugs

Avg: 20%

$67
Average prescription price

Avg: $110

GOPINATH MALLYA M.D.

Psychiatry

2,229

$303K

112
32 are 65+

11%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 20%

$136
Average prescription price

Avg: $110

DANIEL SHAW MD

Psychiatry

2,207

$341K

116
21 are 65+

10%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 20%

$155
Average prescription price

Avg: $110

RAYMOND CAVANAUGH M.D.

Psychiatry

2,202

$157K

115
15 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

11%
prescriptions for brand name drugs

Avg: 20%

$71
Average prescription price

Avg: $110

DAVID GILL M.D.

Psychiatry

2,198

$242K

113
16 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

12%
prescriptions for brand name drugs

Avg: 20%

$110
Average prescription price

Avg: $110

VADIM SECHKIN MD

Psychiatry

2,189

$200K

147
14 are 65+

10%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

14%
prescriptions for brand name drugs

Avg: 20%

$91
Average prescription price

Avg: $110

KIMBERLY LOVETT M.D.

Psychiatry

2,177

$266K

138
27 are 65+

12%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 20%

$122
Average prescription price

Avg: $110

JYOTSNA MHATRE MD

Psychiatry

2,175

$224K

123
43 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 20%

$103
Average prescription price

Avg: $110

JOHN ANEY MD

Psychiatry

2,173

$216K

157
72 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 20%

$99
Average prescription price

Avg: $110

WILLIAM MEEHAN M.D.

Psychiatry

2,138

$185K

132
39 are 65+

20%
patients receiving schedule two controlled substances

Avg: 5%

9%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 20%

$87
Average prescription price

Avg: $110

MARTHA KOUTSOS MD

Psychiatry

2,130

$185K

246
131 are 65+

10%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 20%

$87
Average prescription price

Avg: $110

DANIEL TEPLIN M.D.

Psychiatry

2,129

$170K

184
106 are 65+

14%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 20%

$80
Average prescription price

Avg: $110

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank